Prolactin and CD40 Ligand Levels in Migraine Patients
Author Information
Author(s): Guldiken Sibel, Guldiken Baburhan, Demir Muzaffer, Kabayel Levent, Ozkan Hulya, Turgut Nilda, Hunkar Remziye, Kat Selahattin
Primary Institution: Trakya University Medical Faculty
Hypothesis
The study aimed to investigate the relationship between prolactin levels and subclinical atherosclerosis risk factors such as soluble CD40 ligand and high-sensitivity CRP in migraine patients during the interictal period.
Conclusion
The study found that soluble CD40L levels were significantly higher in migraine patients, indicating a potential link to subclinical atherosclerosis.
Supporting Evidence
- The sCD40L levels were significantly higher in migraine patients compared to controls.
- No difference was found in prolactin levels between migraine patients and controls.
- High-sensitivity CRP levels showed no significant difference between the groups.
- Mean platelet volume was significantly higher in migraine patients.
Takeaway
This study looked at women with migraines and found that a certain protein related to blood vessel health was higher in them, which might mean they have a higher risk for heart problems.
Methodology
Fifty female migraine patients and 25 age-matched female controls were studied, measuring serum levels of sCD40L, hsCRP, and prolactin.
Limitations
The small sample size and the omission of other hormones that influence prolactin action were limitations of the study.
Participant Demographics
All participants were female, with 50 migraine patients and 25 healthy controls.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website